In a mouse thymoma model, E.G7-OVA tumor cells (modified to express CD8 T cell antigen OVA) were injected into mice subcutaneously (s.c), and 2P microscopy was utilized to assess OVA specific CD8 T cells (OTI) dynamics during early and late phases of tumor rejection. The gene discussed is CD8A; the disease is neoplasm.